PMC:7170415 / 10272-11172 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"152","span":{"begin":51,"end":58},"obj":"Species"},{"id":"153","span":{"begin":84,"end":92},"obj":"Disease"},{"id":"159","span":{"begin":248,"end":256},"obj":"Species"},{"id":"160","span":{"begin":722,"end":732},"obj":"Species"},{"id":"161","span":{"begin":810,"end":820},"obj":"Species"},{"id":"162","span":{"begin":831,"end":841},"obj":"Species"},{"id":"163","span":{"begin":844,"end":897},"obj":"Species"}],"attributes":[{"id":"A152","pred":"tao:has_database_id","subj":"152","obj":"Tax:9606"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"MESH:C000657245"},{"id":"A159","pred":"tao:has_database_id","subj":"159","obj":"Tax:9606"},{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"Tax:2697049"},{"id":"A161","pred":"tao:has_database_id","subj":"161","obj":"Tax:2697049"},{"id":"A162","pred":"tao:has_database_id","subj":"162","obj":"Tax:2697049"},{"id":"A163","pred":"tao:has_database_id","subj":"163","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Examples of use cases for diagnostic testing among persons with proven or suspected COVID-19.\nA test well suited for one use case (such as epidemiologic surveillance) may be completely inadequate for another (such as rapid screening of symptomatic patients for allocation of personal protective equipment). For test results to enable a specific clinical decision, test developers, policymakers, and clinicians need to consider each of these with respect to the intention of testing and the population being tested as specifically as possible. For the moment, most use cases placed above the green and gray bar are best met by nucleic acid amplification tests, whereas detection of host-derived antibodies directed against SARS–CoV-2 will be crucial for surveillance, epidemic forecasting, and determination of SARS–CoV-2 immunity. SARS–CoV-2 = severe acute respiratory syndrome–related coronavirus-2."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T45","span":{"begin":84,"end":92},"obj":"Disease"},{"id":"T46","span":{"begin":722,"end":726},"obj":"Disease"},{"id":"T47","span":{"begin":810,"end":814},"obj":"Disease"},{"id":"T48","span":{"begin":831,"end":835},"obj":"Disease"},{"id":"T49","span":{"begin":844,"end":877},"obj":"Disease"}],"attributes":[{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Examples of use cases for diagnostic testing among persons with proven or suspected COVID-19.\nA test well suited for one use case (such as epidemiologic surveillance) may be completely inadequate for another (such as rapid screening of symptomatic patients for allocation of personal protective equipment). For test results to enable a specific clinical decision, test developers, policymakers, and clinicians need to consider each of these with respect to the intention of testing and the population being tested as specifically as possible. For the moment, most use cases placed above the green and gray bar are best met by nucleic acid amplification tests, whereas detection of host-derived antibodies directed against SARS–CoV-2 will be crucial for surveillance, epidemic forecasting, and determination of SARS–CoV-2 immunity. SARS–CoV-2 = severe acute respiratory syndrome–related coronavirus-2."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T93","span":{"begin":37,"end":44},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T94","span":{"begin":94,"end":95},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T95","span":{"begin":96,"end":100},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T96","span":{"begin":311,"end":315},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T97","span":{"begin":334,"end":335},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T98","span":{"begin":364,"end":368},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T99","span":{"begin":474,"end":481},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T100","span":{"begin":507,"end":513},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T101","span":{"begin":653,"end":658},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Examples of use cases for diagnostic testing among persons with proven or suspected COVID-19.\nA test well suited for one use case (such as epidemiologic surveillance) may be completely inadequate for another (such as rapid screening of symptomatic patients for allocation of personal protective equipment). For test results to enable a specific clinical decision, test developers, policymakers, and clinicians need to consider each of these with respect to the intention of testing and the population being tested as specifically as possible. For the moment, most use cases placed above the green and gray bar are best met by nucleic acid amplification tests, whereas detection of host-derived antibodies directed against SARS–CoV-2 will be crucial for surveillance, epidemic forecasting, and determination of SARS–CoV-2 immunity. SARS–CoV-2 = severe acute respiratory syndrome–related coronavirus-2."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":626,"end":638},"obj":"Chemical"},{"id":"T5","span":{"begin":634,"end":638},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"}],"text":"Examples of use cases for diagnostic testing among persons with proven or suspected COVID-19.\nA test well suited for one use case (such as epidemiologic surveillance) may be completely inadequate for another (such as rapid screening of symptomatic patients for allocation of personal protective equipment). For test results to enable a specific clinical decision, test developers, policymakers, and clinicians need to consider each of these with respect to the intention of testing and the population being tested as specifically as possible. For the moment, most use cases placed above the green and gray bar are best met by nucleic acid amplification tests, whereas detection of host-derived antibodies directed against SARS–CoV-2 will be crucial for surveillance, epidemic forecasting, and determination of SARS–CoV-2 immunity. SARS–CoV-2 = severe acute respiratory syndrome–related coronavirus-2."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T9","span":{"begin":668,"end":685},"obj":"http://purl.obolibrary.org/obo/GO_0044405"}],"text":"Examples of use cases for diagnostic testing among persons with proven or suspected COVID-19.\nA test well suited for one use case (such as epidemiologic surveillance) may be completely inadequate for another (such as rapid screening of symptomatic patients for allocation of personal protective equipment). For test results to enable a specific clinical decision, test developers, policymakers, and clinicians need to consider each of these with respect to the intention of testing and the population being tested as specifically as possible. For the moment, most use cases placed above the green and gray bar are best met by nucleic acid amplification tests, whereas detection of host-derived antibodies directed against SARS–CoV-2 will be crucial for surveillance, epidemic forecasting, and determination of SARS–CoV-2 immunity. SARS–CoV-2 = severe acute respiratory syndrome–related coronavirus-2."}

{"project":"LitCovid-sentences","denotations":[{"id":"T77","span":{"begin":0,"end":93},"obj":"Sentence"},{"id":"T78","span":{"begin":94,"end":306},"obj":"Sentence"},{"id":"T79","span":{"begin":307,"end":542},"obj":"Sentence"},{"id":"T80","span":{"begin":543,"end":830},"obj":"Sentence"},{"id":"T81","span":{"begin":831,"end":900},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Examples of use cases for diagnostic testing among persons with proven or suspected COVID-19.\nA test well suited for one use case (such as epidemiologic surveillance) may be completely inadequate for another (such as rapid screening of symptomatic patients for allocation of personal protective equipment). For test results to enable a specific clinical decision, test developers, policymakers, and clinicians need to consider each of these with respect to the intention of testing and the population being tested as specifically as possible. For the moment, most use cases placed above the green and gray bar are best met by nucleic acid amplification tests, whereas detection of host-derived antibodies directed against SARS–CoV-2 will be crucial for surveillance, epidemic forecasting, and determination of SARS–CoV-2 immunity. SARS–CoV-2 = severe acute respiratory syndrome–related coronavirus-2."}